[
  {
    "ts": null,
    "headline": "KeyBanc Sees Injectable GLP-1s Driving Ongoing Demand for WST",
    "summary": "West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 14 Best Dividend Growth Stocks to Buy and Hold in 2026. KeyBanc sees limited risk to oral weight loss drugs through 2030, even with the potential approval of an oral version of Wegovy. In a research note, the firm said oral GLP-1 adoption is likely to […]",
    "url": "https://finnhub.io/api/news?id=666dba922c33bed2fbbb49d766a918de1b2ea71529dc4d396d821555efedc72b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767818313,
      "headline": "KeyBanc Sees Injectable GLP-1s Driving Ongoing Demand for WST",
      "id": 138033860,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 14 Best Dividend Growth Stocks to Buy and Hold in 2026. KeyBanc sees limited risk to oral weight loss drugs through 2030, even with the potential approval of an oral version of Wegovy. In a research note, the firm said oral GLP-1 adoption is likely to […]",
      "url": "https://finnhub.io/api/news?id=666dba922c33bed2fbbb49d766a918de1b2ea71529dc4d396d821555efedc72b"
    }
  }
]